STOCK TITAN
  1. Home
  2. Sec-filings
  3. ICCM
  4. [EFFECT] IceCure Medical Ltd. SEC Filing

[EFFECT] IceCure Medical Ltd. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 23, 2026
Accession Number: 0001213900-26-032332
Submission Type: POS AM
CIK: 0001584371
Company Name: IceCure Medical Ltd.
File Number: 333-288062

Source: View Original Filing on SEC EDGAR

Icecure Medical Ltd.

NASDAQ:ICCM

View ICCM Stock Overview →

ICCM Rankings

#5943 Ranked by Market Cap
N/A Ranked by Dividends

ICCM Latest News

Mar 26, 2026
IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement
Mar 25, 2026
IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates
Mar 24, 2026
IceCure Appoints Meir Peleg as Chief Financial Officer
Mar 17, 2026
IceCure Reports 2025 Full Year Financial & Operational Results
Mar 11, 2026
U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense® Cryoablation in the Local Treatment of Low-Risk Breast Cancer

ICCM Latest SEC Filings

Mar 27, 2026
[424B5] IceCure Medical Ltd. Prospectus Supplement (Debt Securities)
Mar 27, 2026
[SCHEDULE 13D/A] IceCure Medical Ltd. Amended Major Shareholder Report
Mar 27, 2026
[6-K] IceCure Medical Ltd. Current Report (Foreign Issuer)
Mar 25, 2026
[Form 3] IceCure Medical Ltd. Initial Statement of Beneficial Ownership
Mar 25, 2026
[Form 3] IceCure Medical Ltd. Initial Statement of Beneficial Ownership

ICCM Stock Data

28.55M
45.25M
Medical Devices
Healthcare
Link
Israel
Caesarea